Myelodysplastic syndromes

Peter L. Greenberg, Eyal Attar, John M. Bennett, Clara D. Bloomfield, Uma Borate, Carlos M. De Castro, H. Joachim Deeg, Olga Frankfurt, Karin Gaensler, Guillermo Garcia-Manero, Steven D. Gore, David Head, Rami Komrokji, Lori J Maness-Harris, Michael Millenson, Margaret R. O'Donnell, Paul J. Shami, Brady L. Stein, Richard M. Stone, James E. ThompsonPeter Westervelt, Benton Wheeler, Dorothy A. Shead, Maoko Naganuma

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid lineages, and the potential for development of acute myeloid leukemia. These disorders primarily affect older adults. The NCCN Clinical Practice Guidelines in Oncology for MDS provide recommendations on the diagnostic evaluation and classification of MDS, risk evaluation according to established prognostic assessment tools (including the new revised International Prognostic Scoring System), treatment options according to risk categories, and management of related anemia.

Original languageEnglish (US)
Pages (from-to)838-874
Number of pages37
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number7
DOIs
StatePublished - Jul 1 2013

Fingerprint

Myelodysplastic Syndromes
Risk Management
Practice Guidelines
Acute Myeloid Leukemia
Anemia

ASJC Scopus subject areas

  • Oncology

Cite this

Greenberg, P. L., Attar, E., Bennett, J. M., Bloomfield, C. D., Borate, U., De Castro, C. M., ... Naganuma, M. (2013). Myelodysplastic syndromes. JNCCN Journal of the National Comprehensive Cancer Network, 11(7), 838-874. https://doi.org/10.6004/jnccn.2013.0104

Myelodysplastic syndromes. / Greenberg, Peter L.; Attar, Eyal; Bennett, John M.; Bloomfield, Clara D.; Borate, Uma; De Castro, Carlos M.; Deeg, H. Joachim; Frankfurt, Olga; Gaensler, Karin; Garcia-Manero, Guillermo; Gore, Steven D.; Head, David; Komrokji, Rami; Maness-Harris, Lori J; Millenson, Michael; O'Donnell, Margaret R.; Shami, Paul J.; Stein, Brady L.; Stone, Richard M.; Thompson, James E.; Westervelt, Peter; Wheeler, Benton; Shead, Dorothy A.; Naganuma, Maoko.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 11, No. 7, 01.07.2013, p. 838-874.

Research output: Contribution to journalArticle

Greenberg, PL, Attar, E, Bennett, JM, Bloomfield, CD, Borate, U, De Castro, CM, Deeg, HJ, Frankfurt, O, Gaensler, K, Garcia-Manero, G, Gore, SD, Head, D, Komrokji, R, Maness-Harris, LJ, Millenson, M, O'Donnell, MR, Shami, PJ, Stein, BL, Stone, RM, Thompson, JE, Westervelt, P, Wheeler, B, Shead, DA & Naganuma, M 2013, 'Myelodysplastic syndromes', JNCCN Journal of the National Comprehensive Cancer Network, vol. 11, no. 7, pp. 838-874. https://doi.org/10.6004/jnccn.2013.0104
Greenberg PL, Attar E, Bennett JM, Bloomfield CD, Borate U, De Castro CM et al. Myelodysplastic syndromes. JNCCN Journal of the National Comprehensive Cancer Network. 2013 Jul 1;11(7):838-874. https://doi.org/10.6004/jnccn.2013.0104
Greenberg, Peter L. ; Attar, Eyal ; Bennett, John M. ; Bloomfield, Clara D. ; Borate, Uma ; De Castro, Carlos M. ; Deeg, H. Joachim ; Frankfurt, Olga ; Gaensler, Karin ; Garcia-Manero, Guillermo ; Gore, Steven D. ; Head, David ; Komrokji, Rami ; Maness-Harris, Lori J ; Millenson, Michael ; O'Donnell, Margaret R. ; Shami, Paul J. ; Stein, Brady L. ; Stone, Richard M. ; Thompson, James E. ; Westervelt, Peter ; Wheeler, Benton ; Shead, Dorothy A. ; Naganuma, Maoko. / Myelodysplastic syndromes. In: JNCCN Journal of the National Comprehensive Cancer Network. 2013 ; Vol. 11, No. 7. pp. 838-874.
@article{f80e0b6cb3894b04a6023abb320241c5,
title = "Myelodysplastic syndromes",
abstract = "The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid lineages, and the potential for development of acute myeloid leukemia. These disorders primarily affect older adults. The NCCN Clinical Practice Guidelines in Oncology for MDS provide recommendations on the diagnostic evaluation and classification of MDS, risk evaluation according to established prognostic assessment tools (including the new revised International Prognostic Scoring System), treatment options according to risk categories, and management of related anemia.",
author = "Greenberg, {Peter L.} and Eyal Attar and Bennett, {John M.} and Bloomfield, {Clara D.} and Uma Borate and {De Castro}, {Carlos M.} and Deeg, {H. Joachim} and Olga Frankfurt and Karin Gaensler and Guillermo Garcia-Manero and Gore, {Steven D.} and David Head and Rami Komrokji and Maness-Harris, {Lori J} and Michael Millenson and O'Donnell, {Margaret R.} and Shami, {Paul J.} and Stein, {Brady L.} and Stone, {Richard M.} and Thompson, {James E.} and Peter Westervelt and Benton Wheeler and Shead, {Dorothy A.} and Maoko Naganuma",
year = "2013",
month = "7",
day = "1",
doi = "10.6004/jnccn.2013.0104",
language = "English (US)",
volume = "11",
pages = "838--874",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Myelodysplastic syndromes

AU - Greenberg, Peter L.

AU - Attar, Eyal

AU - Bennett, John M.

AU - Bloomfield, Clara D.

AU - Borate, Uma

AU - De Castro, Carlos M.

AU - Deeg, H. Joachim

AU - Frankfurt, Olga

AU - Gaensler, Karin

AU - Garcia-Manero, Guillermo

AU - Gore, Steven D.

AU - Head, David

AU - Komrokji, Rami

AU - Maness-Harris, Lori J

AU - Millenson, Michael

AU - O'Donnell, Margaret R.

AU - Shami, Paul J.

AU - Stein, Brady L.

AU - Stone, Richard M.

AU - Thompson, James E.

AU - Westervelt, Peter

AU - Wheeler, Benton

AU - Shead, Dorothy A.

AU - Naganuma, Maoko

PY - 2013/7/1

Y1 - 2013/7/1

N2 - The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid lineages, and the potential for development of acute myeloid leukemia. These disorders primarily affect older adults. The NCCN Clinical Practice Guidelines in Oncology for MDS provide recommendations on the diagnostic evaluation and classification of MDS, risk evaluation according to established prognostic assessment tools (including the new revised International Prognostic Scoring System), treatment options according to risk categories, and management of related anemia.

AB - The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid lineages, and the potential for development of acute myeloid leukemia. These disorders primarily affect older adults. The NCCN Clinical Practice Guidelines in Oncology for MDS provide recommendations on the diagnostic evaluation and classification of MDS, risk evaluation according to established prognostic assessment tools (including the new revised International Prognostic Scoring System), treatment options according to risk categories, and management of related anemia.

UR - http://www.scopus.com/inward/record.url?scp=84882966505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882966505&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2013.0104

DO - 10.6004/jnccn.2013.0104

M3 - Article

C2 - 23847220

AN - SCOPUS:84882966505

VL - 11

SP - 838

EP - 874

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 7

ER -